Jack Nathan Medical Corp.
JNHMF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -54.5% | 23.6% | 60.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 84.7% | 75.6% | 76.3% | 71.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -17.7% | -22.5% | -28.5% | -63.3% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 85.7% | -34.7% | -45.7% | -81% |
| EPS Diluted | -0.03 | -0.078 | -0.084 | -0.095 |
| % Growth | 61.3% | 7.6% | 11.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |